5/20
01:53 pm
cntx
Are You Looking for a Top Momentum Pick? Why Context Therapeutics Inc. (CNTX) is a Great Choice [Yahoo! Finance]
Low
Report
Are You Looking for a Top Momentum Pick? Why Context Therapeutics Inc. (CNTX) is a Great Choice [Yahoo! Finance]
5/16
07:32 am
cntx
Context Therapeutics Inc. (NASDAQ: CNTX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $4.50 price target on the stock.
Low
Report
Context Therapeutics Inc. (NASDAQ: CNTX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $4.50 price target on the stock.
5/16
07:32 am
cntx
Context Therapeutics Inc. (NASDAQ: CNTX) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $4.50 price target on the stock.
Low
Report
Context Therapeutics Inc. (NASDAQ: CNTX) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $4.50 price target on the stock.
5/14
02:01 pm
cntx
Context Therapeutics Inc. (CNTX) Upgraded to Buy: Here's Why [Yahoo! Finance]
Low
Report
Context Therapeutics Inc. (CNTX) Upgraded to Buy: Here's Why [Yahoo! Finance]
5/9
03:39 pm
cntx
Context Therapeutics Inc. (NASDAQ: CNTX) had its price target raised by analysts at HC Wainwright from $4.00 to $5.00. They now have a "buy" rating on the stock.
Low
Report
Context Therapeutics Inc. (NASDAQ: CNTX) had its price target raised by analysts at HC Wainwright from $4.00 to $5.00. They now have a "buy" rating on the stock.
5/9
01:19 pm
cntx
Context Therapeutics Inc. (NASDAQ: CNTX) had its price target raised by analysts at Maxim Group from $4.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Context Therapeutics Inc. (NASDAQ: CNTX) had its price target raised by analysts at Maxim Group from $4.00 to $10.00. They now have a "buy" rating on the stock.
5/8
04:23 pm
cntx
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results [Yahoo! Finance]
Low
Report
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results [Yahoo! Finance]
5/8
04:06 pm
cntx
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
Low
Report
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
5/2
07:35 am
cntx
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76 [Yahoo! Finance]
Medium
Report
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76 [Yahoo! Finance]
5/2
07:31 am
cntx
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
High
Report
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
5/2
07:30 am
cntx
Context Therapeutics Announces $100 Million Private Placement
Low
Report
Context Therapeutics Announces $100 Million Private Placement
4/1
07:41 am
cntx
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers [Yahoo! Finance]
Medium
Report
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers [Yahoo! Finance]
4/1
07:30 am
cntx
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
Medium
Report
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
3/27
09:19 am
cntx
Companies Like Context Therapeutics (NASDAQ:CNTX) Could Be Quite Risky [Yahoo! Finance]
Medium
Report
Companies Like Context Therapeutics (NASDAQ:CNTX) Could Be Quite Risky [Yahoo! Finance]
3/21
12:34 pm
cntx
Context Therapeutics Inc. (NASDAQ: CNTX) had its price target lowered by analysts at HC Wainwright from $5.00 to $4.00. They now have a "buy" rating on the stock.
Medium
Report
Context Therapeutics Inc. (NASDAQ: CNTX) had its price target lowered by analysts at HC Wainwright from $5.00 to $4.00. They now have a "buy" rating on the stock.
3/21
07:51 am
cntx
Context Therapeutics Reports Full Year 2023 Operating and Financial Results [Yahoo! Finance]
Medium
Report
Context Therapeutics Reports Full Year 2023 Operating and Financial Results [Yahoo! Finance]
3/21
07:43 am
cntx
Context Therapeutics Reports Full Year 2023 Operating and Financial Results
Medium
Report
Context Therapeutics Reports Full Year 2023 Operating and Financial Results